A
Aethlon Medical, Inc. (AEMD)
NCM – Real Time Price. Currency in USD
2.19
0.00 (0.00%)
At close: May 12, 2026, 4:00 PM EDT
2.24
+0.05 (2.21%)
After-hours: May 12, 2026, 5:21 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.19
0.00 (0.00%)
At close: May 12, 2026, 4:00 PM EDT
2.24
+0.05 (2.21%)
After-hours: May 12, 2026, 5:21 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.68 | 3.40 | 10 | |
| Quick ratio | 5.68 | 2.52 | 10 | |
| Debt to Equity | 0.06 | 1.11 | 9.0 | |
| Debt to Assets | 0.05 | 1.58 | 9.0 | |
| Interest coverage | N/A | 4.33 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 294K | 574K | N/A | N/A | N/A |
| Gross Profit | 140K | 309K | -359K | -340K | -547K |
| Operating Income | -10M | -12M | -13M | -9M | -7M |
| Net Income | -10M | -12M | -12M | -13M | -12M |
| EBITDA | -10M | -12M | -12M | -9M | -7M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 93.27 | 5.5 |
| Next quarter | N/A | 91.14 | 5.5 |
| Current year | N/A | 88.1 | 5.5 |
| Next year | N/A | 78.36 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -35.71 | 34.49 | -13.09 | 5.5 |
| Y/Y | 999 | -15 | 76.44 | 6.8 | 6.5 |
| 3y average | 331.41 | -8.86 | 37.49 | 7.51 | 6.8 |
| 5y average | 188.05 | -16.47 | 33.7 | -10.64 | 5.5 |
| Weighted average score | 6.1 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $7.0M significantly exceed its total debt $417.5K, ensuring strong financial flexibility
Total current assets $7.1M exceed Total current liabilities $1.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (1.1), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.9M limits the company's ability to reinvest or pay down debt